Logo image of ACAD

ACADIA PHARMACEUTICALS INC (ACAD) Stock Analyst Ratings

NASDAQ:ACAD - US0042251084 - Common Stock

25.72 USD
+0.4 (+1.58%)
Last: 8/26/2025, 8:13:42 PM
25.72 USD
0 (0%)
After Hours: 8/26/2025, 8:13:42 PM
Buy % Consensus

76

ChartMill assigns a Buy % Consensus number of 76% to ACAD. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 30.32. This target is 17.87% above the current price.
ACAD was analyzed by 26 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about ACAD.
In the previous month the buy percentage consensus was at a similar level.
ACAD was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
ACAD Historical Analyst RatingsACAD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -104 -94 -84 -74 -64 -54 -44 -34 -24 -14 -4 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 25.7217.1731.1130.3242.00 - -33.24% 20.96% 17.87% 63.30%
ACAD Current Analyst RatingACAD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-08-08 UBS Maintains Buy -> Buy
2025-08-07 Mizuho Maintains Neutral -> Neutral
2025-08-07 JMP Securities Maintains Market Outperform -> Market Outperform
2025-08-07 RBC Capital Maintains Outperform -> Outperform
2025-08-07 Goldman Sachs Maintains Sell -> Sell
2025-07-24 JP Morgan Maintains Overweight -> Overweight
2025-06-26 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-06-26 Needham Reiterate Buy -> Buy
2025-06-26 Oppenheimer Maintains Perform -> Perform
2025-06-26 HC Wainwright & Co. Reiterate Buy -> Buy
2025-06-23 RBC Capital Maintains Outperform -> Outperform
2025-06-06 JP Morgan Maintains Overweight -> Overweight
2025-06-05 B of A Securities Maintains Neutral -> Neutral
2025-05-21 Deutsche Bank Upgrade Hold -> Buy
2025-05-20 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2025-05-19 Mizuho Maintains Neutral -> Neutral
2025-05-19 BMO Capital Maintains Outperform -> Outperform
2025-05-19 Needham Maintains Buy -> Buy
2025-05-19 RBC Capital Reiterate Outperform -> Outperform
2025-05-19 Baird Maintains Outperform -> Outperform
2025-05-19 HC Wainwright & Co. Maintains Buy -> Buy
2025-04-28 UBS Maintains Buy -> Buy
2025-04-08 Needham Reiterate Buy -> Buy
2025-02-27 Cantor Fitzgerald Reiterate Overweight -> Overweight
2025-02-27 Needham Reiterate Buy -> Buy
2025-02-27 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-11 Deutsche Bank Initiate Hold
2025-01-03 Guggenheim Downgrade Buy -> Neutral
2024-11-07 Needham Reiterate Buy -> Buy
2024-11-07 HC Wainwright & Co. Reiterate Buy -> Buy